Browse Studies — Arctuva

Phase 3

A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, Controlled, Adaptive Study To Demonstrate The Safety And Efficacy Of DEFENCATH® In Reducing Central Line-Associated Bloodstream Infections (CLABSIs) In Adult And Adolescent Participants Receiving Total Parenteral Nutrition (TPN) Via Central Venous Catheter (CVC)

This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult and ad…

Central Line Associated Blood Stream Infections (CLABSI)

Estimated

~$10 – $8,750

Find your next paid study

Prediction and Reduction of Central Line Associated Blood Stream Infections: A Machine Learning Improvement Study